Leonardo Pescitelli

859 total citations
40 papers, 443 citations indexed

About

Leonardo Pescitelli is a scholar working on Immunology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, Leonardo Pescitelli has authored 40 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 20 papers in Dermatology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Leonardo Pescitelli's work include Psoriasis: Treatment and Pathogenesis (19 papers), Dermatology and Skin Diseases (12 papers) and Autoimmune Bullous Skin Diseases (5 papers). Leonardo Pescitelli is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (19 papers), Dermatology and Skin Diseases (12 papers) and Autoimmune Bullous Skin Diseases (5 papers). Leonardo Pescitelli collaborates with scholars based in Italy. Leonardo Pescitelli's co-authors include Francesca Prignano, Federica Ricceri, Torello Lotti, Claudia Fiorillo, Niccolò Taddei, Matteo Becatti, F. Zanieri, Antonella Di Cesare, Paolo Nassi and Paola Di Gennaro and has published in prestigious journals such as SHILAP Revista de lepidopterología, Experimental Cell Research and Antioxidants and Redox Signaling.

In The Last Decade

Leonardo Pescitelli

39 papers receiving 432 citations

Peers

Leonardo Pescitelli
Anne‐Marie Ros Sweden
Dilek Seçkin Türkiye
Yonghu Sun China
Sara Mazzilli Italy
Nanticha Kamanamool Thailand
Ya‐Chu Tsai Taiwan
Rodolfo Capizzi Italy
Pekka Erkko Finland
Jens Roar Bjerke Norway
Luisa Senra Switzerland
Anne‐Marie Ros Sweden
Leonardo Pescitelli
Citations per year, relative to Leonardo Pescitelli Leonardo Pescitelli (= 1×) peers Anne‐Marie Ros

Countries citing papers authored by Leonardo Pescitelli

Since Specialization
Citations

This map shows the geographic impact of Leonardo Pescitelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonardo Pescitelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonardo Pescitelli more than expected).

Fields of papers citing papers by Leonardo Pescitelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonardo Pescitelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonardo Pescitelli. The network helps show where Leonardo Pescitelli may publish in the future.

Co-authorship network of co-authors of Leonardo Pescitelli

This figure shows the co-authorship network connecting the top 25 collaborators of Leonardo Pescitelli. A scholar is included among the top collaborators of Leonardo Pescitelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonardo Pescitelli. Leonardo Pescitelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dini, Valentina, Leonardo Pescitelli, Nicola Milanesi, et al.. (2025). Upadacitinib dose adjustment in moderate‐to‐severe atopic dermatitis: insights from a multicenter real‐world study. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 23(12). 1597–1600. 1 indexed citations
2.
Magnano, Michela, Susanna Rossari, Emanuele Trovato, et al.. (2024). Risankizumab in Oncologic Patients With Psoriasis: A Case Series. SHILAP Revista de lepidopterología. 4(2). 558–560. 1 indexed citations
3.
Brizzi, Eugenia Veronica Di, Stefano Caccavale, Roberta Di Caprio, et al.. (2024). Prospective Real-Life Multicenter Study of Tildrakizumab 200 mg for Moderate-to-Severe Psoriasis: Who Is the Ideal Patient?. Dermatology Practical & Conceptual. 14(4). e2024284–e2024284. 3 indexed citations
4.
Lorenzoni, E, Antonella Di Cesare, Emanuele Trovato, et al.. (2024). Risankizumab in very elderly patients in real-world practice. Italian Journal of Dermatology and Venereology. 159(6). 695–696. 1 indexed citations
5.
Ricceri, Federica, Susanna Rossari, Michela Magnano, et al.. (2023). Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation. Italian Journal of Dermatology and Venereology. 159(1). 64–65. 1 indexed citations
6.
Cesare, Antonella Di, et al.. (2020). SB5 adalimumab biosimilar in the treatment of psoriasis and psoriatic arthritis. Dermatologic Therapy. 33(3). e13435–e13435. 12 indexed citations
7.
8.
Borgognoni, Lorenzo, et al.. (2020). Efficacy of Electrochemotherapy in the Treatment of Cutaneous Melanoma Metastases and Rare Non-melanoma Skin Cancer. Anticancer Research. 40(11). 6485–6492. 18 indexed citations
9.
Ricceri, Federica, et al.. (2020). Clinical experience with adalimumab biosimilar imraldi in hidradenitis suppurativa. Dermatologic Therapy. 33(6). e14387–e14387. 18 indexed citations
10.
Stinco, Giuseppe, Nicola Balato, Cinzia Buligan, et al.. (2019). A multicenter retrospective case-control study on Suspension of TNF-inhibitors and Outcomes in Psoriatic patients (STOP study). Giornale Italiano di Dermatologia e Venereologia. 154(4). 392–399. 7 indexed citations
11.
Pescitelli, Leonardo, et al.. (2019). Clinical experience with the etanercept biosimilar SB4 in psoriatic patients. International Journal of Clinical Pharmacy. 41(1). 9–12. 12 indexed citations
12.
Donetti, Elena, Laura Cornaghi, Francesca Arnaboldi, et al.. (2017). Epidermal barrier reaction to an in vitro psoriatic microenvironment. Experimental Cell Research. 360(2). 180–188. 12 indexed citations
13.
Donetti, Elena, Laura Cornaghi, Francesca Arnaboldi, et al.. (2016). Interleukin 22 early affects keratinocyte differentiation, but not proliferation, in a three-dimensional model of normal human skin. Experimental Cell Research. 345(2). 247–254. 18 indexed citations
14.
Pescitelli, Leonardo, et al.. (2016). A Pediatric Case of Sclerodermatous Graft‐Versus‐Host Disease Responsive to Ultraviolet A1 Phototherapy. Pediatric Dermatology. 33(2). e99–102. 4 indexed citations
15.
Pescitelli, Leonardo, Federica Ricceri, & Francesca Prignano. (2014). Tuberculosis Reactivation Risk in Dermatology. PubMed. 91(0). 65–70. 7 indexed citations
16.
Prignano, Francesca, et al.. (2011). Development of MGUS in psoriatic patients: a possible undiagnosed event during anti‐TNF‐α‐treatment. Journal of the European Academy of Dermatology and Venereology. 26(11). 1444–1448. 7 indexed citations
17.
Prignano, Francesca, Federica Ricceri, Leonardo Pescitelli, Diletta Bonciani, & Torello Lotti. (2011). Etanercept therapy in a hepatitis B virus (HBV)‐positive psoriatic patient developing a monoclonal gammopathy of undetermined significance. International Journal of Dermatology. 50(8). 999–1001. 4 indexed citations
18.
Prignano, Francesca, Leonardo Pescitelli, Matteo Becatti, et al.. (2009). Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. Journal of Dermatological Science. 54(3). 157–167. 55 indexed citations
19.
Prignano, Francesca, Leonardo Pescitelli, Federica Ricceri, & Torello Lotti. (2009). Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities. Journal of the European Academy of Dermatology and Venereology. 24(5). 555–560. 8 indexed citations
20.
Prignano, Francesca, Leonardo Pescitelli, Federica Ricceri, & Torello Lotti. (2008). The importance of genetical link in immuno‐mediated dermatoses: psoriasis and vitiligo. International Journal of Dermatology. 47(10). 1060–1062. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne‐Marie Ros Breakdown of academic impact, for papers by Dilek Seçkin Breakdown of academic impact, for papers by Yonghu Sun Breakdown of academic impact, for papers by Sara Mazzilli Breakdown of academic impact, for papers by Nanticha Kamanamool Breakdown of academic impact, for papers by Ya‐Chu Tsai Breakdown of academic impact, for papers by Rodolfo Capizzi Breakdown of academic impact, for papers by Pekka Erkko Breakdown of academic impact, for papers by Jens Roar Bjerke Breakdown of academic impact, for papers by Luisa Senra
Rankless by CCL
2026